IRIS
MARCHETTI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.785
EU - Europa 4.242
AS - Asia 3.957
SA - Sud America 537
AF - Africa 51
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 14.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.661
SG - Singapore 1.703
CN - Cina 1.224
UA - Ucraina 703
IE - Irlanda 654
IT - Italia 629
GB - Regno Unito 492
SE - Svezia 482
BR - Brasile 454
TR - Turchia 408
DE - Germania 403
FR - Francia 336
FI - Finlandia 206
IN - India 177
VN - Vietnam 162
RU - Federazione Russa 131
CA - Canada 71
HK - Hong Kong 61
PL - Polonia 42
MX - Messico 41
KR - Corea 39
AR - Argentina 36
CZ - Repubblica Ceca 28
BE - Belgio 26
NL - Olanda 25
BD - Bangladesh 23
JP - Giappone 22
ES - Italia 21
IQ - Iraq 19
TW - Taiwan 19
AT - Austria 17
ID - Indonesia 17
PK - Pakistan 16
ZA - Sudafrica 16
EC - Ecuador 14
IL - Israele 13
IR - Iran 11
EU - Europa 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
CO - Colombia 9
KE - Kenya 7
MA - Marocco 7
MY - Malesia 7
AU - Australia 6
CL - Cile 6
VE - Venezuela 6
GR - Grecia 5
MK - Macedonia 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
BA - Bosnia-Erzegovina 4
LB - Libano 4
SA - Arabia Saudita 4
UY - Uruguay 4
CH - Svizzera 3
ET - Etiopia 3
NG - Nigeria 3
NP - Nepal 3
RO - Romania 3
TN - Tunisia 3
UG - Uganda 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
GD - Grenada 2
MN - Mongolia 2
NI - Nicaragua 2
SN - Senegal 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MV - Maldive 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
Totale 14.589
Salva come PNG Salva come JPEG
Città #
Singapore 1.259
Jacksonville 843
Chandler 823
Dublin 645
Ashburn 346
Princeton 323
Beijing 319
Dallas 297
Southend 288
Izmir 239
Nanjing 239
Los Angeles 163
Santa Clara 154
Munich 153
Wilmington 137
Cambridge 132
Dearborn 120
Tongling 114
Altamura 108
The Dalles 104
New York 100
Ann Arbor 90
Boardman 89
Buffalo 71
Nanchang 71
Chieti 69
Helsinki 63
Pescara 59
Hong Kong 58
Shenyang 55
Ho Chi Minh City 51
Redondo Beach 44
São Paulo 44
Hebei 39
Tianjin 39
Seoul 36
Rome 35
Warsaw 35
Woodbridge 35
Kunming 31
Brooklyn 29
Hangzhou 28
Milan 28
Denver 26
Grevenbroich 25
Washington 25
Hanoi 24
Chennai 23
Norwalk 22
Rio de Janeiro 22
Stockholm 22
Augusta 21
Brussels 21
Chicago 21
Jiaxing 20
London 20
San Mateo 20
Atlanta 19
Toronto 19
Collecorvino 18
Boston 17
Brno 17
Hefei 17
Houston 17
Montreal 17
Nuremberg 17
Poplar 17
Mexico City 16
Orange 16
Tokyo 16
Belo Horizonte 15
Council Bluffs 14
Orem 14
Phoenix 14
Taichung 14
Johannesburg 13
Latina 13
Turku 13
Changsha 12
Frankfurt am Main 12
Guangzhou 12
Vienna 12
Hyderabad 11
Jinan 11
Ningbo 11
San Francisco 11
Seattle 11
Fairfield 10
Falls Church 10
New Delhi 10
Zhengzhou 10
Baghdad 9
Da Nang 9
Dong Ket 9
Lanzhou 9
Tappahannock 9
Ancona 8
Andover 8
Brasília 8
Campinas 8
Totale 8.870
Salva come PNG Salva come JPEG
Nome #
Developing a Decision-making Model Based on an Interdisciplinary Oncological Care Group for the Management of Colorectal Cancer 253
Assessing EGFR mutations. 218
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 182
A unique microRNA signature associated with plaque instability in humans. 173
A multidisciplinary group for prostate cancer management: A single institution experience 161
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: Results of the first italian external quality assurance scheme 159
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays 157
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 152
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. 151
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. 146
Analysis of DNA Glycosylases MUTYH and OGG1 and Their Correlation with EGFR Signalling in Normal and Nodular Thyroid Tissues 136
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. 135
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors 135
A unique microRNA signature associated with ischemic stroke in humans 134
Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. 128
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 127
KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment. 126
ROS1 Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm 125
Evaluation of DNA Base Excision Repair and ErbB signaling in euthyroid goiters 124
AKT1(E17K) in human solid tumours 123
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 122
Why anti-PD1/PDL1 therapy is so effective? Another piece in the puzzle 122
HIGH-RISK HUMAN PAPILLOMA VIRUS INFECTION, TUMOR PATHOPHENOTYPES AND BRCA1/2 AND P53 STATUS IN JUVENILE BREAST CANCER PATIENTS. 121
Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer 117
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 116
Mutational profile of GNAQQ209 in human tumors. 116
Primary pleuro-pulmonary synovial sarcoma: a single-center 13-year experience 115
Int6 expression can predict survival in early-stage non-small cell lung cancer patients. 115
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 114
Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas. 114
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma. 112
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 112
2nd ESMO consensus conference on lung cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up 112
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. 111
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation 108
Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor 108
Correspondence - In Reply - Limitations of Single-Strand Conformation Polymorphism Analysis As a High-Throughput Method for the Detection of EGFR Mutations in the Clinical Setting 107
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. 106
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. 106
2nd ESMO Consensus Conference in Lung Cancer: Locally advanced stage III non-small-cell lung cancer 106
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 106
POLE exonuclease domain mutations in endometrial carcinoma: a case report 105
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. 105
PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. 104
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 104
Association between cigarette smoking and FHIT gene alterations in lung cancer. 104
Absence of somatic mutations in the coding region of the waf1/cip1 gene in human breast, lung and ovarian carcinomas - a polymorphism at codon-31. 104
Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up 103
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: A new algorithm for patient selection and personalized treatment 103
The chromosomal location of the mouse mammary tumor gene Int6 and related pseudogenes in the mouse genome. 102
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. 102
Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non–Small-cell Lung Cancer: Clinical and Budget Effect 102
Survivin gene expression in early-stage non-small cell lung cancer. 101
Telomerase activity as a prognostic indicator in Stage I Non- Small Cell Lung Cancer -Gruppo Italiano di Patologia Molecolare II Riunione Scientifica. Pisa 20-22 Giugno99 100
Lung tumours from non-smoking subjects: A p53-related genetic instability in a subset of cases. 100
p53 alterations in non-small cell lung cancer correlate with metastatic involvement of hilar and mediastinal lymph nodes 100
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications. 100
microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer. 100
Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project 100
Enriched SSCP: a highly sensitive method for the detection of unknown mutations. Application to the molecular diagnosis of lung cancer in sputum samples. 99
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. 99
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis. 99
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors. 99
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. 98
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. 98
Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients 98
Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients 97
Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors. 96
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice 95
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. 94
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. 94
mdm2 gene alterations and mdm2 protein expression in breast carcinomas 94
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. 94
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies 94
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. 94
The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. 93
Bronchioloalveolar carcinoma: K-ras mutations are constant events in the mucinous subtype 92
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe 92
Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. 91
2nd ESMO Consensus Conference on Lung Cancer: Non-small-cell lung cancer first-line/second and further lines in advanced disease 91
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments 91
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones. 90
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: Results from the ETOP Lungscape Project 90
Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry — Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort 90
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations 90
Genetic analysis of lung tumors of non-smoking subject: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus 89
Hypertension modulates miR-145 expression in human atherosclerotic plaques 89
Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. 88
A percutaneous large-needle aspiration biopsy technique for histologic examination of the testis in infertile patients. 87
PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapy 87
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer. 86
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 86
K-ras mutations and cetuximab in colorectal cancer. 85
Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. 84
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. 84
Nucleotide and deduced amino acid sequences of tumor gene INT6. 82
Predictive markers in lung cancer: A few hints for the practicing pathologist 82
K-RAS mutation in the tumour of Ferrante I of Aragon, King of Naples. 81
Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer 80
p95HER2 Truncated Form in Resected Non-small Cell Lung Cancer. 79
Totale 10.971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021481 0 0 0 0 0 189 20 10 79 130 9 44
2021/2022806 26 14 10 133 53 34 24 55 64 40 107 246
2022/20232.275 221 307 106 268 229 445 138 145 289 15 64 48
2023/20241.013 97 27 63 28 67 294 208 42 11 34 6 136
2024/20253.159 158 598 499 72 74 125 164 161 326 143 326 513
2025/20262.782 452 314 544 684 585 203 0 0 0 0 0 0
Totale 14.918